{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05794581",
            "orgStudyIdInfo": {
                "id": "CT-868-005"
            },
            "organization": {
                "fullName": "Carmot Therapeutics, Inc.",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes",
            "officialTitle": "A Randomized, Double-Blind, Placebo and Comparator-Controlled Crossover Study to Assess the Effects of CT-868 Treatment on Glucose Homeostasis in Participants With Type 1 Diabetes",
            "therapeuticArea": [
                "Endocrinology"
            ],
            "study": "a-study-to-assess-the-effects-of-ct-treatment-on-glucose-homeostasis-in-participants-with-type-diabetes"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2023-03-21",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-03-10",
            "studyFirstSubmitQcDate": "2023-03-30",
            "studyFirstPostDateStruct": {
                "date": "2023-04-03",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-06-21",
            "lastUpdatePostDateStruct": {
                "date": "2023-06-22",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Carmot Therapeutics, Inc.",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "This study will be conducted primarily to evaluate the effects of CT-868 on glucose homeostasis in participants with Type 1 Diabetes Mellitus."
        },
        "conditionsModule": {
            "conditions": [
                "Type 1 Diabetes"
            ],
            "keywords": [
                "Type 1 Diabetes",
                "Obesity",
                "Overweight"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "CROSSOVER",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 24,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "CT-868",
                    "type": "EXPERIMENTAL",
                    "description": "SC injection of CT-868 Intervention",
                    "interventionNames": [
                        "Drug: CT-868"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "SC injection of placebo matching CT-868 dose",
                    "interventionNames": [
                        "Drug: Placebo"
                    ]
                },
                {
                    "label": "Victoza",
                    "type": "ACTIVE_COMPARATOR",
                    "description": "SC injection of active comparator",
                    "interventionNames": [
                        "Drug: Victoza"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "CT-868",
                    "description": "CT-868",
                    "armGroupLabels": [
                        "CT-868"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Placebo",
                    "description": "Placebo as SC Injection",
                    "armGroupLabels": [
                        "Placebo"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Victoza",
                    "description": "Victoza as active comparator as SC Injection",
                    "armGroupLabels": [
                        "Victoza"
                    ],
                    "otherNames": [
                        "Liraglutide"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "To assess area under the curve (AUC) in glucose metabolism during MMTT",
                    "timeFrame": "Baseline up to 4 days"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "To assess changes in continuous glucose monitoring (CGM) measures",
                    "timeFrame": "Baseline up to 4 days"
                },
                {
                    "measure": "Area under the acetaminophen concentration-time (AUC)",
                    "timeFrame": "0 - 300 minutes"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Female or male adults with Type 1 diabetes\n* Ages 18-65 years\n* Type 1 DM for at least 3 years\n* Using an insulin pump or multiple daily injections (MDI) for at least 3 months\n* BMI 25.0 - 35.0\n\nExclusion Criteria:\n\n* Significant medical history\n* Uncontrolled diabetes\n* History of surgical treatment for weight loss\n* History of malignancy",
            "healthyVolunteers": true,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "maximumAge": "65 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Michael Elliott",
                    "role": "CONTACT",
                    "phone": "510-666-6328",
                    "email": "melliott@carmot.us"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Michael Elliott",
                    "affiliation": "Carmot Therapeutics, Inc.",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Carmot Clinical Research Unit 101",
                    "status": "RECRUITING",
                    "city": "Chula Vista",
                    "state": "California",
                    "zip": "91911",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.64005,
                        "lon": -117.0842
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Carmot Therapeutics, Inc.",
                    "url": "https://carmot-therapeutics.us/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003920",
                    "term": "Diabetes Mellitus"
                },
                {
                    "id": "D000003922",
                    "term": "Diabetes Mellitus, Type 1"
                }
            ],
            "ancestors": [
                {
                    "id": "D000044882",
                    "term": "Glucose Metabolism Disorders"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000004700",
                    "term": "Endocrine System Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12701",
                    "name": "Obesity",
                    "relevance": "LOW"
                },
                {
                    "id": "M26186",
                    "name": "Overweight",
                    "relevance": "LOW"
                },
                {
                    "id": "M7117",
                    "name": "Diabetes Mellitus, Type 1",
                    "asFound": "Type 1 Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M7115",
                    "name": "Diabetes Mellitus",
                    "asFound": "Diabetes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M25403",
                    "name": "Glucose Metabolism Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M7862",
                    "name": "Endocrine System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000069450",
                    "term": "Liraglutide"
                }
            ],
            "ancestors": [
                {
                    "id": "D000097789",
                    "term": "Glucagon-Like Peptide-1 Receptor Agonists"
                },
                {
                    "id": "D000007004",
                    "term": "Hypoglycemic Agents"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000054795",
                    "term": "Incretins"
                },
                {
                    "id": "D000006728",
                    "term": "Hormones"
                },
                {
                    "id": "D000006730",
                    "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M419",
                    "name": "Liraglutide",
                    "asFound": "Place",
                    "relevance": "HIGH"
                },
                {
                    "id": "M9043",
                    "name": "Glucagon",
                    "relevance": "LOW"
                },
                {
                    "id": "M26997",
                    "name": "Glucagon-Like Peptide 1",
                    "relevance": "LOW"
                },
                {
                    "id": "M3401",
                    "name": "Glucagon-Like Peptide-1 Receptor Agonists",
                    "relevance": "LOW"
                },
                {
                    "id": "M10054",
                    "name": "Hypoglycemic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M27905",
                    "name": "Incretins",
                    "relevance": "LOW"
                },
                {
                    "id": "M9789",
                    "name": "Hormones",
                    "relevance": "LOW"
                },
                {
                    "id": "M9788",
                    "name": "Hormone Antagonists",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Hypo",
                    "name": "Hypoglycemic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "Gast",
                    "name": "Gastrointestinal Agents"
                }
            ]
        }
    },
    "hasResults": false
}